Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary

Modern Pathology

Volumn 24, Issue 2, 2011, Pages 277-287

  Ota, Takayo ^a   Clayton, Amy C ^a   Minot, Douglas M ^a   Shridhar, Viji ^a   Hartmann, Lynn C ^a   Gilks, C Blake ^b   Chien, Jeremy R ^a  

^a MAYO CLINIC   (United States)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

immunohistochemistry; MCM7; ovarian cancer

Indexed keywords

MINICHROMOSOME MAINTENANCE PROTEIN 7;

ADULT; ARTICLE; AUTOMATION; CANCER GRADING; DNA MICROARRAY; DNA SYNTHESIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; UNIVARIATE ANALYSIS; VALIDATION PROCESS;

CELL COUNT; CELL CYCLE PROTEINS; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; NEOPLASM STAGING; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PROGNOSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79551646236     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.202     Document Type: Article

References (26)

1. Jemal A, Siegel R,Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
2. Gadducci A, Fuso L, Cosio S, et al. Are surveillance procedures of clinical benefit for patients treated for ovarian cancer?: A retrospective Italian multicentric study. Int J Gynecol Cancer 2009;19:367-374.
3. Sabatier R, Finetti P, Cervera N, et al. Gene expression profiling and prediction of clinical outcome in ovarian cancer. Crit Rev Oncol Hematol 2009;72:98-109.
4. Gadducci A, Cosio S, Tana R, et al. Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer. Crit Rev Oncol Hematol 2009;69:12-27.
5. Gilks CB, Vanderhyden BC, Zhu S, et al. Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling. Gynecol Oncol 2005;96:684-694.
6. Bonome T, Lee JY, Park DC, et al. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. Cancer Res 2005;65: 10602-10612.
7. Marchini S, Mariani P, Chiorino G, et al. Analysis of gene expression in early-stage ovarian cancer. Clin Cancer Res 2008;14:7850-7860.
8. Chien J, Fan JB, Bell DA, et al. Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer. Gynecol Oncol 2009;114:3-11.
9. Tye BK. MCM proteins in DNA replication. Annu Rev Biochem 1999;68:649-686.
10. Forsburg SL. Eukaryotic MCM proteins: beyond replication initiation. Microbiol Mol Biol Rev 2004;68:109-131.
11. Forsburg SL. The MCM helicase: linking checkpoints to the replication fork. Biochem Soc Trans 2008;36: 114-119.
12. Li SS, Xue WC, Khoo US, et al. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis. Histopathology 2005;46:307-313.
13. Ren B, Yu G, Tseng GC, et al. MCM7 amplification and overexpression are associated with prostate cancer progression. Oncogene 2006;25:1090-1098.
14. Tsai HY, Hsi BL, Hung IJ, et al. Correlation of MYCN amplification with MCM7 protein expression in neuroblastomas: a chromogenic in situ hybridization study in paraffin sections. Hum Pathol 2004;35:1397-1403.
15. Nishihara K, Shomori K, Fujioka S, et al. Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance. Int J Oncol 2008;33:245-251.
16. Fujioka S, Shomori K, Nishihara K, et al. Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication. Lung Cancer 2009;65:223-229.
17. Facoetti A, Ranza E, Benericetti E, et al. Minichromosome maintenance protein 7: a reliable tool for glioblastoma proliferation index. Anticancer Res 2006; 26:1071-1075.
18. Gambichler T, Breininger A, Rotterdam S, et al. Expression of minichromosome maintenance proteins in Merkel cell carcinoma. J Eur Acad Dermatol Venereol 2009;23:1184-1188.
19. Goodman MT, Shvetsov YB. Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004. Cancer Epidemiol Biomarkers Prev 2009;18:132-139.
20. Suzuki S, Adachi A, Hiraiwa A, et al. Cloning and characterization of human MCM7 promoter. Gene 1998;216:85-91.
21. Ohtani K, Iwanaga R, Nakamura M, et al. Cell growthregulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F. Oncogene 1999;18:2299-2309.
22. Tye BK, Chang VK. Dual functional regulators coordinate DNA replication and gene expression in proliferating cells. Front Biosci 2004;9:2548-2555.
23. Shohet JM, Hicks MJ, Plon SE, et al. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma. Cancer Res 2002;62:1123-1128.
24. Stoeber K, Tlsty TD, Happerfield L, et al. DNA replication licensing and human cell proliferation. J Cell Sci 2001;114:2027-2041.
25. Mayer A, Takimoto M, Fritz E, et al. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer 1993;71:2454-2460.
26. Tan DS, Kaye S. Ovarian clear cell adenocarcinoma: a continuing enigma. J Clin Pathol 2007;60:355-360.